MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-07-2026
Charles River Laboratories International Long Term Debt Current 2011-2026 | CRL
Annual Long Term Debt Current Charles River Laboratories International
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 57.7 M | 54.2 M | 54.9 M | 46.5 M | 33.3 M | 24.7 M | 20.4 M | 28.2 M | 28.5 M | 24.6 M | 15.2 M | 31.7 M | 21.2 M | -139 M | 14.7 M | 30.5 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 57.7 M | -139 M | 21.7 M |
Long Term Debt Current of other stocks in the Diagnostics research industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Co-Diagnostics
CODX
|
662 K | $ 1.31 | -19.63 % | $ 1.74 M |  USA |
 |
Castle Biosciences
CSTL
|
1.32 M | $ 19.11 | 1.19 % | $ 554 M | USA |
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
1.44 M | $ 15.85 | -2.1 % | $ 479 M | USA |
 |
Aspira Women's Health
AWH
|
202 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | USA |
 |
Illumina
ILMN
|
79 M | $ 142.72 | -0.36 % | $ 22.7 B | USA |
 |
Interpace Biosciences
IDXG
|
431 K | $ 1.8 | - | $ 7.96 M | USA |
 |
CareDx, Inc
CDNA
|
6.52 M | $ 19.85 | -3.12 % | $ 1.06 B | USA |
 |
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
16 K | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | USA |
 |
Lantheus Holdings
LNTH
|
3.8 M | $ 93.78 | -2.99 % | $ 6.33 B | USA |
 |
Medpace Holdings
MEDP
|
23.2 M | $ 418.32 | -0.2 % | $ 12.1 B | USA |
 |
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M |  China |
 |
Mettler-Toledo International
MTD
|
35.1 M | $ 1 038.75 | -0.3 % | $ 21.4 B |  Schweiz |
 |
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | China |
 |
Myriad Genetics
MYGN
|
6.9 M | $ 3.62 | - | $ 335 M | USA |
 |
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | USA |
 |
NeoGenomics
NEO
|
4.78 M | $ 8.29 | -0.9 % | $ 1.06 B | USA |
 |
National Research Corporation
NRC
|
451 K | $ 18.61 | -1.69 % | $ 417 M | USA |
 |
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
7.64 M | $ 188.15 | -4.45 % | $ 18.5 B | USA |
 |
Exact Sciences Corporation
EXAS
|
33.6 M | - | - | $ 19.8 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
241 M | $ 25.27 | -0.96 % | $ 24 B |  Niderland |
 |
Guardant Health
GH
|
27.7 M | $ 94.27 | -4.45 % | $ 11.8 B | USA |
 |
Personalis
PSNL
|
6.89 M | $ 6.38 | -4.92 % | $ 569 M | USA |
 |
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
24.3 M | $ 116.56 | -0.45 % | $ 9.61 B |  Irlanda |
 |
Senseonics Holdings
SENS
|
496 K | $ 5.72 | -1.72 % | $ 239 M | USA |
 |
Soleno Therapeutics
SLNO
|
726 K | $ 53.0 | 0.01 % | $ 2.69 B | USA |
 |
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
358 K | $ 2.25 | -6.67 % | $ 5.17 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
191 M | $ 252.68 | -0.53 % | $ 21 B | USA |
 |
Thermo Fisher Scientific
TMO
|
275 M | $ 438.85 | -2.07 % | $ 165 B | USA |
 |
Celcuity
CELC
|
54 K | $ 135.17 | 0.33 % | $ 6.32 B | USA |
 |
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | Israel |
 |
Twist Bioscience Corporation
TWST
|
13.8 M | $ 48.65 | -8.12 % | $ 2.91 B | USA |
 |
Neogen Corporation
NEOG
|
5.64 M | $ 8.21 | -2.61 % | $ 1.78 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
174 M | $ 187.55 | -0.21 % | $ 20.8 B | USA |
 |
Invitae Corporation
NVTA
|
14.6 M | - | - | $ 21.2 M | USA |